Portugal, Spain and the new biotech frontier

Portugal, Spain and the new biotech frontier

From BioSpace by BioSpace

June 10, 2026 · 21 min

About this episode

This episode explores the rise of Southern Europe's biotech ecosystem with insights from industry experts.

In this episode of Denatured, as part of our series on the European life sciences investment ecosystem, you'll hear from Hannah Franklin, associate at Biovance Capital and Pablo Gabriel Cironi Lopez, director of life science investment at Caixa Capital Risc. We examine the rise of Southern Europe’s biotech ecosystem—from Portugal’s efforts to turn strong science into startups to Spain’s growing depth of capital and talent—and what it will take for the region to compete globally. Host ⁠Jennifer C. Smith-Parker , Director of Insights, BioSpace Guests Hannah Franklin , Associate, Biovance Capital Pablo Gabriel Cironi Lopez , Director, Life Science Investment, Caixa Capital Risc Disclaimer: The views expressed in this discussion by guests are their own and do not represent those of their organizations.

People in this episode

Host: Jennifer C. Smith-Parker

Guests: Hannah Franklin, Pablo Gabriel Cironi Lopez

Topics covered

  • biotech ecosystem
  • life sciences investment
  • Southern Europe
  • startups
  • capital and talent
  • global competition

Keywords

  • biotech
  • investment
  • Portugal
  • Spain
  • life sciences
  • startups
  • capital
  • talent

Mentioned in this episode

Organizations: Biovance Capital, Caixa Capital Risc

Places: Portugal, Spain, Southern Europe

More episodes of BioSpace

Explore listener stats, chart rankings, contacts and more on the BioSpace podcast page.